受强制性开放获取政策约束的文章 - Jennifer Huellein了解详情
整体HelmholtzDFGBMBFEuropean CommissionNIHCancer Research UKSwedish Research CouncilMRCGovernment of SpainEMBLWellcomeSCFDoDCIHRBanking Foundation "la Caixa"Academy of FinlandKnut and Alice Wallenberg FoundationBlood Cancer UKNIHRSCLKWFGovernment of ItalyAIRC Foundation for Cancer Research in ItalyDamon Runyon Cancer Research Foundation
无法在其他位置公开访问的文章:7 篇
Comprehensive genomic and transcriptomic analysis for guiding therapeutic decisions in patients with rare cancers
P Horak, C Heining, S Kreutzfeldt, B Hutter, A Mock, J Hüllein, M Fröhlich, ...
Cancer discovery 11 (11), 2780-2795, 2021
强制性开放获取政策: Helmholtz Association
The impact of SF3B1 mutations in CLL on the DNA-damage response
GD te Raa, IAM Derks, V Navrkalová, A Skowronska, PD Moerland, ...
Leukemia 29 (5), 1133-1142, 2015
强制性开放获取政策: Dutch Cancer Society
TP53 mutation and survival in aggressive B cell lymphoma
T Zenz, M Kreuz, M Fuge, W Klapper, H Horn, AM Staiger, D Winter, ...
International Journal of Cancer 141 (7), 1381-1388, 2017
强制性开放获取政策: Canadian Institutes of Health Research
MED12 mutations and NOTCH signalling in chronic lymphocytic leukaemia
B Wu, M Słabicki, L Sellner, S Dietrich, X Liu, A Jethwa, J Hüllein, ...
British journal of haematology 179 (3), 421-429, 2017
强制性开放获取政策: Helmholtz Association
MDM4 is targeted by 1q gain and drives disease in Burkitt lymphoma
J Hüllein, M Słabicki, M Rosolowski, A Jethwa, S Habringer, K Tomska, ...
Cancer research 79 (12), 3125-3138, 2019
强制性开放获取政策: Helmholtz Association, European Commission
Dissection of CD20 regulation in lymphoma using RNAi
M Słabicki, KS Lee, A Jethwa, L Sellner, F Sacco, T Walther, J Hüllein, ...
Leukemia 30 (12), 2409-2412, 2016
强制性开放获取政策: US National Institutes of Health, European Molecular Biology Laboratory …
Phenotypic differentiation does not affect tumorigenicity of primary human colon cancer initiating cells
TD Dubash, CM Hoffmann, F Oppel, KM Giessler, S Weber, SM Dieter, ...
Cancer letters 371 (2), 326-333, 2016
强制性开放获取政策: German Research Foundation, Helmholtz Association
可在其他位置公开访问的文章:23 篇
Targeting the BRAF V600E mutation in multiple myeloma
M Andrulis, N Lehners, D Capper, R Penzel, C Heining, J Huellein, ...
Cancer discovery 3 (8), 862-869, 2013
强制性开放获取政策: US National Institutes of Health
Drug-perturbation-based stratification of blood cancer
S Dietrich, M Oleś, J Lu, L Sellner, S Anders, B Velten, B Wu, J Huellein, ...
The Journal of clinical investigation 128 (1), 427-445, 2018
强制性开放获取政策: US National Institutes of Health, Helmholtz Association, Academy of Finland …
Evolution of DNA methylation is linked to genetic aberrations in chronic lymphocytic leukemia
CC Oakes, R Claus, L Gu, Y Assenov, J Hüllein, M Zucknick, M Bieg, ...
Cancer discovery 4 (3), 348-361, 2014
强制性开放获取政策: US National Institutes of Health
BRAF inhibition in hairy cell leukemia with low-dose vemurafenib
S Dietrich, A Pircher, V Endris, F Peyrade, CM Wendtner, GA Follows, ...
Blood, The Journal of the American Society of Hematology 127 (23), 2847-2855, 2016
强制性开放获取政策: Cancer Research UK
Genomic analysis of hairy cell leukemia identifies novel recurrent genetic alterations
BH Durham, B Getta, S Dietrich, J Taylor, H Won, JM Bogenberger, ...
Blood, The Journal of the American Society of Hematology 130 (14), 1644-1648, 2017
强制性开放获取政策: US Department of Defense, US National Institutes of Health, Damon Runyon …
Clonal diversity predicts adverse outcome in chronic lymphocytic leukemia
AC Leeksma, J Taylor, B Wu, JR Gardner, J He, M Nahas, M Gonen, ...
Leukemia 33 (2), 390-402, 2019
强制性开放获取政策: US National Institutes of Health
Elucidation of tonic and activated B-cell receptor signaling in Burkitt’s lymphoma provides insights into regulation of cell survival
J Corso, KT Pan, R Walter, C Doebele, S Mohr, H Bohnenberger, ...
Proceedings of the National Academy of Sciences 113 (20), 5688-5693, 2016
强制性开放获取政策: German Research Foundation, Blood Cancer UK, UK Medical Research Council …
Multi-omics reveals clinically relevant proliferative drive associated with mTOR-MYC-OXPHOS activity in chronic lymphocytic leukemia
J Lu, E Cannizzaro, F Meier-Abt, S Scheinost, PM Bruch, HAR Giles, ...
Nature cancer 2 (8), 853-864, 2021
强制性开放获取政策: German Research Foundation, European Molecular Biology Laboratory, Helmholtz …
Comprehensive cancer predisposition testing within the prospective MASTER trial identifies hereditary cancer patients and supports treatment decisions for rare cancers
A Jahn, A Rump, TJ Widmann, C Heining, P Horak, B Hutter, ...
Annals of Oncology 33 (11), 1186-1199, 2022
强制性开放获取政策: Helmholtz Association
TRRAP is essential for regulating the accumulation of mutant and wild-type p53 in lymphoma
A Jethwa, M Słabicki, J Hüllein, M Jentzsch, V Dalal, S Rabe, L Wagner, ...
Blood, The Journal of the American Society of Hematology 131 (25), 2789-2802, 2018
强制性开放获取政策: US National Institutes of Health, Helmholtz Association, European Commission …
The protein landscape of chronic lymphocytic leukemia
F Meier-Abt, J Lu, E Cannizzaro, MF Pohly, S Kummer, S Pfammatter, ...
Blood, The Journal of the American Society of Hematology 138 (24), 2514-2525, 2021
强制性开放获取政策: European Commission, Federal Ministry of Education and Research, Germany …
Requirement for YAP1 signaling in myxoid liposarcoma
M Trautmann, YY Cheng, P Jensen, N Azoitei, I Brunner, J Hüllein, ...
EMBO molecular medicine 11 (5), e9889, 2019
强制性开放获取政策: German Research Foundation, Helmholtz Association, Swedish Research Council …
Drug‐microenvironment perturbations reveal resistance mechanisms and prognostic subgroups in CLL
PM Bruch, HAR Giles, C Kolb, SA Herbst, T Becirovic, T Roider, J Lu, ...
Molecular Systems Biology 18 (8), e10855, 2022
强制性开放获取政策: German Research Foundation, Federal Ministry of Education and Research, Germany
出版信息和资助信息由计算机程序自动确定